Pharmafile Logo
Pharmafocus logo
Advanced Search
novartis_window

Novartis in collaboration deal worth potential $1.2 billion with Cerulean

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerulean, NDC, Novartis

Novartis has signed an agreement with Cerulean Pharma, worth a potential $1.2 billion depending on milestones met, to co-develop nanoparticle-drug …

News
celgene_1_02

Celgene’s Otezla approved by NICE for chronic plaque psoriasis

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, NICE, apremilast, otezla

NICE has given its approval to another indication for Celgene’s Otezla (apremilast), meaning NHS patients now have access to the …

News

MSD’s antiviral drug hits endpoint targets in Phase III trials

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …

News
f_44819

Oxford Genetics boosts cell/gene therapy R&D with new facility

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford Genetics, expansion

Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its infrastructure and staff to keep …

News

Specialist Clinical Trials Equipment Supplier Woodley Equipment Company Exhibiting at OCT Southern California

October 19, 2016

Woodley Equipment is exhibiting at Outsourcing in Clinical Trials Southern California taking place on 26th and 27th October 2016 at …

News
Press release
vaccine3a-062568e

Sun Pharma partners with ICGEB to develop dengue vaccine

October 19, 2016
Research and Development Vaccine, dengue, icgeb, sun pharmaceutical

Indian drug firm Sun Pharma is set to join forces with the International Centre for Generic Engineering and Biotechnology (ICGEB) …

News
lilly_corporate_hq

Lilly announces plan to expand global access to health care

October 19, 2016
Research and Development Eli Lilly, Lilly 30x30, global health

Eli Lilly has announced a project, known as Lilly 30×30, which is a five-year, $90 million investment to improve access …

News

Roche’s immunotherapy cancer drug given FDA approval

October 19, 2016
Research and Development Cancer, FDA, Genentech, Roche, immunotherapy, lung cancer

Coming off the back of earlier positive news this month, Roche has revealed that their drug, Tecentriq, has been given …

News

Recipharm to open largest Nordic GLP bioanalysis lab

October 19, 2016
Manufacturing and Production, Research and Development Recipharm, Sweden, expansion

Contract development and manufacturing firm Recipharm has announced plans to invest five million Swedish Krona (SEK) in a new GLP-compliant …

News
fdaoutsideweb

FDA grants $23 million to boost research on rare diseases

October 19, 2016
Research and Development Cancer, FDA, clinical trials, oncology

The FDA has continued their push to provide funding for experimental clinical trials into treatments of rare diseases. The FDA, …

News
shutterstock_138095450

Quark to set up “largest biotechnology fund in Canada” for $500m

October 18, 2016
Manufacturing and Production, Research and Development Canada, Quark Venture, Vancouver, fund

Canadian venture capital firm Quark Venture is to partner up with China’s GF Securities to launch a “largest of its …

News
pillsphotos1

Research suggests that anti-inflammatory drugs may offer alternative to anti-depressants

October 18, 2016
Manufacturing and Production University of Cambridge, anti-cytokine, anti-inflammatory, depression

Researchers at the University of Cambridge analysed data from 20 clinical trials involving anti-cytokine drugs, which are commonly used to …

News
c_agsandrew_-_fotolia

IBM and Quest forge precision cancer treatment partnership

October 18, 2016
Manufacturing and Production, Medical Communications Cancer, Precision Medicine, Quest, ibm, oncology

IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …

News
pfizer_sky

Pfizer sets release date for rival to J&J’s blockbuster drug

October 18, 2016
Manufacturing and Production J&J, JJ, Johnson & Johnson, Pfizer, Remicade, inflectra

Pfizer have announced that they will begin shipping their rival to Johnson & Johnson’s Remicade by the end of November. …

News
ipos0_l

Regeneron and Teva’s experimental drug halted by FDA clinical hold

October 17, 2016
Manufacturing and Production Regeneron, Teva, back pain, osteoarthritis

Regeneron Pharmaceuticals and Teva Pharmaceuticals had only just agreed a deal worth a potential $2.6 billion to co-develop Regeneron’s fasinumab …

News

Wickham Laboratories Announces Renewal of FDA Accreditation

October 17, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Wickham Laboratories announces that the United States Food and Drug Administration (FDA) inspection conducted 15th-17th of February 2016 has now …

News
Press release
shutterstock_38078521

Apitope reclaims multiple sclerosis treatment from Merck after 7 years

October 17, 2016
Sales and Marketing ATX-MS-1467, Apitope, Merck, multiple sclerosis

Apitope has announced it has reclaimed the global rights to its multiple sclerosis (MS) treatment ATX-MS-1467 from Merck for the …

News
valeant_logo

Valeant Pharmaceutical release their latest price increases

October 17, 2016
Sales and Marketing

Valeant Pharmaceutical announced, on 14 October, that their Patient Access and Pricing Committee had decided on a price range increase …

News
hanmi

Hanmi Pharmaceutical raided over insider trading suspicions

October 17, 2016
Sales and Marketing Boehringer Ingelheim, Genentech, Hanmi Pharmaceutical, south korea

At the end of September, we reported on a busy 24-hour for Hanmi Pharmaceutical, as they secured a deal with …

News
ema_building_face_web

EMA grants conditional approval for biliary cholangitis treatment

October 17, 2016
Sales and Marketing EMA, intercept, ocaliva, primary biliary cholangitis

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has voiced its approval of Intercept’s Ocaliva …

News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026